Abstract: Incentives are offered by merchants, delivery services, issuers, acquirers, and transaction handlers are made to an account holder to make an authorized e-commerce transaction for the delivery of a purchase in exchange for the offerors making a donation to the account holder's designed charity. To incent purchases from local merchants, the incentive may limit the donation by a derivation of navigation time between account holder and merchant. The consumer uses any one of several different merchant websites to check-out so as to purchase the selected goods and services in the account holder's virtual shopping cart that the account holder selected from any of the several different merchant websites, while avoiding interacting with third party vendors. The consumer shops with different merchants at different webpages without requiring the account holder to use a separate permission or log-in for each different merchant.

Abstract: Systems, methods, devices and computer-readable media for generating incentives for a loyalty system are described. A method includes: receiving, at at least one processor, data reflective of transactions conducted by a plurality of customers; processing, at the at least one processor, the data to determine a set of attributes for each of the plurality of customers; classifying, at the at least one processor, each of the plurality of customers according to at least one of a plurality of customer groups based on the determined set of attributes; and generating, at the at least one processor, an incentive targeting customers in at least one of the plurality of customer groups.

Abstract: Customers receive an incentive with use of an installed cellphone app to image an AR-bearing ad. Matches between data from the customer's accounts for each merchant are compared to the data in association with the customer's logical identifier for their cellphone, and particularly with each incidence of a rendering on their display screen of an AR view of a product advertisement containing the AR-triggering symbol to initiate the corresponding AR enhanced view of the ad. In conjunction with chronological time stamping of occurrences, a likelihood is derived that the customer's viewing of the AR enhanced product advertisement influenced the potential customer's subsequent purchase of the corresponding advertised product as evidenced within the potential customer's rich transactional data from the customer's debit and/or credit accounts. The certainty of each match is determined to further initiate the merchant's incentive to the customer which may be the merchant's donation to a community program.

Abstract: A technique for generating a performance prediction of a machine learning model with uncertainty intervals includes obtaining a first model configured to perform a task and a production dataset. At least one metric predicting a performance of the first model at performing the task on the production dataset is generated using a second model. The second model is a meta-model associated with the first model. At least one value predicting an uncertainty of the at least one metric predicting the performance of the first model at performing the task on the production dataset is generated using a third model. The third model is a meta-meta-model associated with the second model. An indication of the at least one metric and the at least one value is provided.

Abstract: Customers receive an incentive with use of an installed cellphone app to image an AR-bearing ad. Matches between data from the customer's accounts for each merchant are compared to the data in association with the customer's logical identifier for their cellphone, and particularly with each incidence of a rendering on their display screen of an AR view of a product advertisement containing the AR-triggering symbol to initiate the corresponding AR enhanced view of the ad. In conjunction with chronological time stamping of occurrences, a likelihood is derived that the customer's viewing of the AR enhanced product advertisement influenced the potential customer's subsequent purchase of the corresponding advertised product as evidenced within the potential customer's rich transactional data from the customer's debit and/or credit accounts. The certainty of each match is determined to further initiate the merchant's incentive to the customer which may be the merchant's donation to a community program.

Abstract: The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Abstract: Systems, data access management utilities, and methods generate links between local merchants and community programs, whereby the merchant may provide incentives to customers in relation to community programs. The implementations may track community programs, as well as online and offline customer transactions with merchants that make use of the incentive. Implementations may include as participants, customers, merchants, community organizations, intermediaries, and other groups or individuals. Participants may have participant identifiers, which may be linked to a payment source. Data may be collected about all participants, either expressly, or from offline or online transactions between merchants and customers utilizing a participant identifier, and the data may be stored in a data storage area.

Abstract: The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds of Formula (I) and pharmaceutical compositions of the present invention.

Abstract: The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Abstract: The present invention relates to compounds that, inhibit KRas G12C, In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Abstract: Systems, methods, devices and computer-readable media for generating incentives for a loyalty system are described. A method includes: receiving, at at least one processor, data reflective of transactions conducted by a plurality of customers; processing, at the at least one processor, the data to determine a set of attributes for each of the plurality of customers; classifying, at the at least one processor, each of the plurality of customers according to at least one of a plurality of customer groups based on the determined set of attributes; and generating, at the at least one processor, an incentive targeting customers in at least one of the plurality of customer groups.

Abstract: A consumer in a community submits one request for an offer from each of a multiple of community merchants to supply a product or service within a time frame, where the merchant whose offer is accepted by the consumer will make a merchant-defined donation to a community charity selected by the consumer, and where the community is defined by mode-specific navigational transportation travel times between the merchant and the consumer during the time frame. The consumer's request is electronically forwarded to each merchant in response to which the consumer electronically receives offers from the merchants validated for compliance with specifics of the consumer's request, and the consumer thereafter electronically accepts one such compliant offer. The consumer is surveyed with an incentive-bearing request to assess the merchant's performance on the accepted offer, where the incentive can be a further donation to the charity.

Abstract: The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Abstract: Methods, systems and computer program products for improving ground truth quality for modeling are provided. Aspects include receiving a plurality of data inputs, wherein each of the plurality of data inputs has an associated label. Aspects also include training a model based on the plurality of data inputs. Aspects also include generating a plurality of vector representations corresponding to the plurality of data inputs based on the model. Aspects also include clustering the plurality of vector representations into one or more clusters. Aspects also include identifying at least one anomalous data input based on the one or more clusters. The at least one anomalous data input can be a data input of the plurality of data inputs that is mislabeled, contributes to an ambiguous class structure or is an outlier. Aspects also include outputting a notification that provides an indication of the at least one anomalous data input.

Abstract: The generating of actionable recommendations for tuning model metrics of an Artificial Intelligence (AI) system includes partitioning a key performance indicator (KPI) range associated with a target system into a plurality of buckets. Log data including at least one KPI of the target system and one or more AI model metrics is partitioned and distributed across the plurality of buckets. For each bucket, an aggregate value of the one or more AI model metrics across the log data is computed and weighted according to the volume of log data in that bucket. A correlation factor between the aggregate value and a representative KPI value for each bucket is determined. A model tuning recommendation to increase ranking of the AI model metrics according to the determined correlation factor is provided to an output device and/or to the AI system for updating the one or more AI model.

Abstract: Implementations generate links between local merchants and community programs. Merchants provide incentives to customers in relation to community programs. Implementations also include online and offline customer transactions with merchants that make use of incentives. Implementation pertain to customers that view a broadcast of content that is interleaved with a merchant's advertisement and analytic reporting. Matches between transactions with a merchant and a customer that view a broadcast of content that is interleaved with the merchant's advertisement may be identified by the system, and a level of certainty that the match is accurate may be determined. These implementations can be operated by an alliance of entities that cooperate in order to facilitate, and benefit from, transactions between customers and merchants, where the customer is incented to conduct the transaction with the merchant by the merchant's agreement to make a donation to an entity of the customer's choice.

Abstract: The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Abstract: Methods, devices and media for a pre-enrollment registration system are described.

Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.